Summary
Fibroblasts from most patients with Ehlers-Danlos syndrome (EDS) type IV, a disorder characterized by fragility of skin, blood vessels, and internal organs, secrete reduced amounts of type III procollagen. In 7 of 8 cell strains analyzed, we found evidence of structural defects in half of the type III procollagen chains synthesized, such as deletions or bona fide amino acid substitutions, which cause delayed formation and destabilization of the collagen triple helix and, as a consequence, reduced secretion of the molecule. The data suggest that EDS type IV is often caused by heterozygosity for mutations at the COL3A1 locus, which affect the structure of type III procollagen. The triple-helical region of the molecule, like the homologous region of type I procollagen, appears to be particularly vulnerable.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Aumailley M, Poschl E, Martin GR, Yamada, Y, Muller PK (1988) Low production of procollagen III by skin fibroblasts from patients with Ehlers-Danlos syndrome type IV is not caused by decreased levels of procollagen III mRNA. Eur J Clin Invest 18: 207–212
Benson-Chanda V, Su MW, Weil D, Chu ML, Ramirez F (1989) Cloning and analysis of the 5′ portion of the human type III procollagen gene (COL3A1). Gene (in press)
Bruckner P, Prockop DJ (1981) Proteolytic enzymes as probes for the triple-helical conformation of procollagen. Anal Biochem 110: 360–368
Byers PH, Holbrook KA, Barsh GS, Smith LT, Bornstein P (1981) Altered secretion of type III procollagen in a form of type IV. Ehlers-Danlos syndrome. Lab Invest 44:336–341
Byers PH, Holbrook KA, Barsh GS (1983) Ehlers-Danlos syndrome. In: Emery AEH, Rimoin DL (eds) Principles and practice of medical genetics. Churchill-Livingstone, Edinburgh, pp 836–850
Byers PH, Wenstrup RJ, Bonadio JF, Starman B, Cohn DH (1987) Molecular basis of inherited disorders of collagen biosynthesis: implications for prenatal diagnosis. Curr Probl Dermatol 16:158–174
Byers PH, Tsipouras P, Bonadio JF, Starman BJ, Schwartz RC (1988) Perinatal lethal osteogenesis imperfecta (OI type II): a biochemically heterogeneous disorder usually due to new mutations in the genes for type I collagen. Am J Hum Genet 42:237–248
Chu ML, Williams CJ, Pepe G, Hirsch JL, Prockop DJ, Ramirez F (1983) Internal deletion in a collagen gene in a perinatal lethal form of osteogenesis imperfecta. Nature 304:78–80
Kadler KE, Vogel BE, Hojima Y, Prockop DJ (1988) A type I collagen with a cysteine-kink produces collagen fibrils with frayed end and limits polymerization of the normal monomer. Coll Relat Res 8:505–506
Laskey RA, Mills AD (1975) Quantitative film detection of 3H and 14C in polyacrylamide gels by fluorography. Eur J Biochem 56: 335–341
Maniatis T, Fritsch EF, Sambrook J (eds) (1982) Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
Nicholls AC, De Paepe A, Narcisi P, Dalgleish R, De Keyser F, Matton M, Pope FM (1988) Linkage of a polymorphic marker for the type III collagen gene (COL3A1) to atypical autosomal dominant Ehlers-Danlos syndrome type IV in a large Belgian pedigree. Hum Genet 78:276–281
Pope FM, Martin GR, Lichtenstein JR, Penttinen R, Gerson B, Rowe DW, McKusick VA (1975) Patients with Ehlers-Danlos syndrome type IV lack type III collagen. Proc Natl Acad Sci USA 72:1314–1316
Pope FM, Martin GR, McKusick VA (1977) Inheritance of Ehlers-Danlos type IV syndrome. J Med Genet 14:200–204
Pope FM, Nicholls AC, Jones PM, Wells RS, Lawrence D (1980) EDS IV (acrogeria): new autosomal dominant and recessive types. J R Soc Med 73:180–185
Ramirez F, Sangiorgi FO, Tsipouras P (1986) Human collagens: biochemical, molecular and genetic features in normal and diseased states. In: Blasi F (ed) Human genes and diseases. Wiley, Chichester New York, pp 341–375
Steinmann B, Rao VH, Vogel A, Bruckner P, Gitzelmann R, Byers PH (1984) Cysteine in the triple-helical domain of one allelic product of the α1(I) gene of type I collagen produces a lethal form of osteogenesis imperfecta. J Biol Chem 259:11129–11138
Steinmann B, Superti-Furga A, Royce PM (1988) Imperfect collagenesis in osteogenesis imperfecta. Ann NY Acad Sci 543:47–61
Steinmann B, Superti-Furga A, Joller-Jemelka HI, Cetta G, Byers PH (1989) Ehlers-Danlos syndrome type IV — a subset of patients distinguished by low serum levels of the aminoterminal propeptide of type III procollagen. Am J Med Genet 33 (in press)
Stolle CA, Pyeritz RE, Myers JC, Prockop DJ (1985) Synthesis of an altered type III procollagen in a patient with type IV Ehlers-Danlos syndrome. J Biol Chem 260:1937–1944
Superti-Furga A, Steinmann B (1988) Impaired secretion of type III procollagen in Ehlers-Danlos syndrome type IV fibroblasts: correction of the defect by incubation at reduced temperature and demonstration of subtle alterations in the triple-helical region of the molecule. Biochem Biophys Res Commun 150:140–147
Superti-Furga A, Gugler E, Gitzelmann R, Steinmann B (1988) Ehlers-Danlos syndrome type IV: a multi-exon deletion in one of the tow COL3A1 alleles affecting structure, stability and processing of type III procollagen. J Biol Chem 263:6226–6232
Temple AS, Hinton P, Narcisi P, Pope FM (1988) Detection of type III collagen in skin fibroblasts from patients with Ehlers-Danlos syndrome type IV by immunofluorescence. Br J Dermatol 118: 17–26
Tsipouras P, Byers PH, Schwartz RC, Chu ML, Weil D, Pepe G, Cassidy SB, Ramirez F (1986) Ehlers-Danlos syndrome type IV: cosegregation of the phenotype to a COL3A1 allele of type III procollagen. Hum Genet 74:41–46
Willing MC, Cohn DH, Starman B, Holbrook K, Greenberg CR, Byers PH (1988) Heterozygosity for a large deletion in the α2(I) collagen gene has a dramatic effect on type I collagen secretion and produces perinatal lethal osteogenesis imperfecta. J Biol Chem 263:8398–8404
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Superti-Furga, A., Steinmann, B., Ramirez, F. et al. Molecular defects of type III procollagen in Ehlers-Danlos syndrome type IV. Hum Genet 82, 104–108 (1989). https://doi.org/10.1007/BF00284038
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00284038